Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Whitcombe

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Iscience|August 26, 2024
An acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and <i>Streptococcus pyogenes</i>-specific antibodiesNatalie Lorenz, Reuben McGregor, Alana L Whitcombe, et al.
Epidemiology and Infection|October 20, 2021
Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New ZealandLauren H Carlton, Tiffany Chen, Alana L Whitcombe, et al.
Clinical & Translational Immunology|March 22, 2021
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New ZealandAlana L Whitcombe, Reuben McGregor, Alyson Craigie, et al.
Nature Communications|December 3, 2024
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsJoshua Osowicki, Hannah R Frost, Kristy I Azzopardi, et al.
Immunology and Cell Biology|November 20, 2019
Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic feverAmy W Chung, Timothy Kc Ho, Paulina Hanson-Manful, et al.
Peerj|September 21, 2020
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New ZealandReuben McGregor, Alana L Whitcombe, Campbell R Sheen, et al.
Vaccine|July 6, 2022
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccineThomas Hills, Aimee Paterson, Rebecca Woodward, et al.
The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Antibody responses against bacterial glycans affinity mature and diversify in germinal centersHolly A Fryer, Catherine Pitt, Hannah R Frost, et al.
Nature Medicine|September 24, 2025
Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Iscience|August 26, 2024
An acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and <i>Streptococcus pyogenes</i>-specific antibodiesNatalie Lorenz, Reuben McGregor, Alana L Whitcombe, et al.
Epidemiology and Infection|October 20, 2021
Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New ZealandLauren H Carlton, Tiffany Chen, Alana L Whitcombe, et al.
Clinical & Translational Immunology|March 22, 2021
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New ZealandAlana L Whitcombe, Reuben McGregor, Alyson Craigie, et al.
Nature Communications|December 3, 2024
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsJoshua Osowicki, Hannah R Frost, Kristy I Azzopardi, et al.
Immunology and Cell Biology|November 20, 2019
Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic feverAmy W Chung, Timothy Kc Ho, Paulina Hanson-Manful, et al.
Peerj|September 21, 2020
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New ZealandReuben McGregor, Alana L Whitcombe, Campbell R Sheen, et al.
Vaccine|July 6, 2022
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccineThomas Hills, Aimee Paterson, Rebecca Woodward, et al.
The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Antibody responses against bacterial glycans affinity mature and diversify in germinal centersHolly A Fryer, Catherine Pitt, Hannah R Frost, et al.
Nature Medicine|September 24, 2025
Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Pageof 3